Research article - Peer-reviewed, 2013
Longitudinal Analysis of Quality of Life, Clinical, Radiographic, Echocardiographic, and Laboratory Variables in Dogs with Myxomatous Mitral Valve Disease Receiving Pimobendan or Benazepril: The QUEST Study
Häggström, Jens; Boswood, A.; O'Grady, Michael; Jöns, O.; Smith, S.; Swift, S.; Borgarelli, Michele; Gavaghan, Brad; Kvart, Clarence; DiFruscia, RockyAbstract
Conclusions and Clinical ImportancePimobendan versus benazepril resulted in similar QoL during the study, but conferred increased time before intensification of CHF treatment. Pimobendan treatment resulted in smaller heart size, higher body temperature, and less retention of free water.Keywords
Canine; Mitral regurgitation; Mortality; TherapyPublished in
Journal of Veterinary Internal Medicine2013, volume: 27, number: 6, pages: 1441-1451
Publisher: WILEY-BLACKWELL
Authors' information
Swedish University of Agricultural Sciences, Department of Clinical Sciences
Boswood, A.
Royal Veterinary College
O'Grady, Michael
Jöns, O.
Boehringer Ingelheim Vetmedica GmbH
Smith, S.
Scarsdale Veterinary Hospital
Swift, S.
Northwest Surgeons
Borgarelli, Michele
Gavaghan, Brad
Swedish University of Agricultural Sciences, Department of Anatomy, Physiology and Biochemistry (AFB)
DiFruscia, Rocky
UKÄ Subject classification
Other Veterinary Science
Publication Identifiers
DOI: https://doi.org/10.1111/jvim.12181
URI (permanent link to this page)
https://res.slu.se/id/publ/51698